Warren Buffett is looking to make a deal. A big deal. In his recent annual letter to Berkshire Hathaway
We will need both good performance from our current businesses and more major acquisitions. We're prepared. Our elephant gun has been reloaded, and my trigger finger is itchy.
My colleague Morgan Housel says that with the $20 billion to $30 billion of unencumbered cash Berkshire has on hand to make an acquisition, "Berkshire buys something huge in China, another U.S. utility company, or another conglomerate like Marmon Holdings." I think Morgan is likely right, though I think there are other options on the table. In an interview with CNBC's Becky Quick, Buffett gave some hints as to what he's looking for:
- It's easier for Berkshire to buy privately owned businesses than ones trading on the market. A 20% premium to market price is something he doesn't want to pay, with very few exceptions.
- An acquisition is more likely to be in the United States than any other place, though they haven't bought their last international company.
- He would prefer to buy an entire company in contrast to having a minority stake.
In addition to those criteria, I'll add a few more based on Buffett's investing style and prior transactions:
- He'll be looking for a durable franchise that will be as strong (or stronger) 20 years from now as it is today.
- Buffett will want a business with pricing power. These are companies that can raise prices without driving customers to the competition.
- He covets superb management that will continue to run the business without hand-holding from Omaha.
And the winners are ...
I think two compelling elephant-size acquisition candidates are cereal makers General Mills
Take the breakfast cereal industry, whose return on invested capital is more than double that of the auto insurance industry (which is why companies like Kellogg and General Mills sell at five times book value and most large insurers sell close to book). The cereal companies regularly impose price increases, few of them related to a significant jump in their costs. Yet not a peep is heard from consumers.
General Mills and Kellogg have enterprise values of $30 billion and $25 billion, respectively, which puts them right in the sweet spot for Buffett's elephant hunting. The major hang-up would most likely be price. Both stocks are trading near 10 times EV/EBITDA and I doubt Buffett would want to pay an acquisition premium in excess of that amount, even for superb businesses like these.
Another candidate in the food industry is H.J. Heinz
While Buffett has stated his preference to buy entire companies, Berkshire does take large minority stakes in publicly traded companies. Outside of the food industry, Berkshire's multibillion-dollar positions in health-care stalwarts Johnson & Johnson and sanofi-aventis catch my eye. Another blue-chip stock in that space that's looking attractive right now is Abbott Laboratories
Abbott Labs is a cream-of-the-crop health-care company with diverse business segments, including pharmaceuticals, medical devices, and a nutritional business. Abbott's stock is trading at just 10 times its 2011 earnings guidance, so the price could be right for Berkshire to put a couple billion dollars to work. The only drawback is that with an enterprise value of $88 billion, Abbott is too big for Berkshire to absorb.
Foolish final thoughts
I think all four of these companies have the potential to be attractive investments for Berkshire Hathaway if the stars were to come into the right alignment. The quality of the businesses is indisputable and the sticking point would be price. The highest caliber businesses are rarely cheap, especially for a discriminating investor like Buffett.
Click here for a free report containing three more stocks Buffett wishes he could buy.
Charly does not own shares of any company mentioned in this article. Berkshire Hathaway and Johnson & Johnson are Motley Fool Inside Value selections. Berkshire Hathaway is a Motley Fool Stock Advisor selection. HJ Heinz, Johnson & Johnson, and Kellogg are Motley Fool Income Investor recommendations. Motley Fool Options has recommended a diagonal call position on Johnson & Johnson. The Fool owns shares of Abbott Laboratories, Berkshire Hathaway, and Johnson & Johnson. Motley Fool Alpha owns shares of Abbott Laboratories and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.